1. |
Shinn SH, Schaff HV. Evidence-based surgical management of acquired tricuspid valve disease. Nat Rev Cardiol, 2013, 10(4): 190-203.
|
2. |
Asmarats L, Taramasso M, Rodés-Cabau J. Tricuspid valve disease: Diagnosis, prognosis and management of a rapidly evolving field. Nat Rev Cardiol, 2019, 16(9): 538-554.
|
3. |
Izumi C, Iga K, Konishi T. Progression of isolated tricuspid regurgitation late after mitral valve surgery for rheumatic mitral valve disease. J Heart Valve Dis, 2002, 11(3): 353-356.
|
4. |
Dreyfus GD, Corbi PJ, Chan KM, et al. Secondary tricuspid regurgitation or dilatation: Which should be the criteria for surgical repair? Ann Thorac Surg, 2005, 79(1): 127-132.
|
5. |
Buzzatti N, Iaci G, Taramasso M, et al. Long-term outcomes of tricuspid valve replacement after previous left-side heart surgery. Eur J Cardiothorac Surg, 2014, 46(4): 713-719.
|
6. |
Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation, 2021, 143(5): e72-e227.
|
7. |
Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J, 2022, 43(7): 561-632.
|
8. |
Guy TS, Hill AC. Mitral valve prolapse. Annu Rev Med, 2012, 63: 277-292.
|
9. |
Lancellotti P, Moura L, Pierard LA, et al. European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 2: Mitral and tricuspid regurgitation (native valve disease). Eur J Echocardiogr, 2010, 11(4): 307-332.
|
10. |
Nath J, Foster E, Heidenreich PA. Impact of tricuspid regurgitation on long-term survival. J Am Coll Cardiol, 2004, 43(3): 405-409.
|
11. |
Enriquez-Sarano M, Messika-Zeitoun D, Topilsky Y, et al. Tricuspid regurgitation is a public health crisis. Prog Cardiovasc Dis, 2019, 62(6): 447-451.
|
12. |
Mick SL. The tricuspid valve: No longer forgotten but still not well understood. J Am Coll Cardiol, 2021, 77(6): 725-727.
|
13. |
Hahn RT, Asch F, Weissman NJ, et al. Impact of tricuspid regurgitation on clinical outcomes: The COAPT trial. J Am Coll Cardiol, 2020, 76(11): 1305-1314.
|
14. |
Badhwar V, Rankin JS, He M, et al. Performing concomitant tricuspid valve repair at the time of mitral valve operations is not associated with increased operative mortality. Ann Thorac Surg, 2017, 103(2): 587-593.
|
15. |
Rodríguez-Palomares JF, Lozano-Torres J, Dentamaro I, et al. Predictors of cardiovascular outcomes after surgery in severe tricuspid regurgitation: Clinical, imaging and hemodynamic prospective study. Rev Esp Cardiol (Engl Ed), 2021, 74(8): 655-663.
|
16. |
Rommel KP, Besler C, Noack T, et al. Physiological and clinical consequences of right ventricular volume overload reduction after transcatheter treatment for tricuspid regurgitation. JACC Cardiovasc Interv, 2019, 12(15): 1423-1434.
|
17. |
Pettinari M, De Kerchove L, Lazam S, et al. Mid-term results of a randomized trial of tricuspid annuloplasty for less-than-severe functional tricuspid regurgitation at the time of mitral valve surgery†. Eur J Cardiothorac Surg, 2019, 55(5): 851-858.
|
18. |
Zhong Y, Bai W, Wang H, et al. Impact of concomitant tricuspid annuloplasty on right ventricular remodeling in patients with rheumatic mitral valve disease. Cardiovasc Ultrasound, 2021, 19(1): 16.
|
19. |
Pahwa S, Saran N, Pochettino A, et al. Outcomes of tricuspid valve surgery in patients with functional tricuspid regurgitation. Eur J Cardiothorac Surg, 2021, 59(3): 577-585.
|
20. |
Cao JY, Wales KM, Zhao DF, et al. Repair of less than severe tricuspid regurgitation during left-sided valve surgery: A meta-analysis. Ann Thorac Surg, 2020, 109(3): 950-958.
|
21. |
Brescia AA, Ward ST, Watt TMF, et al. Outcomes of guideline-directed concomitant annuloplasty for functional tricuspid regurgitation. Ann Thorac Surg, 2020, 109(4): 1227-1232.
|
22. |
Gammie JS, Chu MWA, Falk V, et al. Concomitant tricuspid repair in patients with degenerative mitral regurgitation. N Engl J Med, 2022, 386(4): 327-339.
|
23. |
Jeganathan R, Armstrong S, Al-Alao B, et al. The risk and outcomes of reoperative tricuspid valve surgery. Ann Thorac Surg, 2013, 95(1): 119-124.
|
24. |
Bertrand PB, Koppers G, Verbrugge FH, et al. Tricuspid annuloplasty concomitant with mitral valve surgery: Effects on right ventricular remodeling. J Thorac Cardiovasc Surg, 2014, 147(4): 1256-1264.
|
25. |
程显声. 二尖瓣外科术后晚期三尖瓣反流发病机制的探讨. 中国循环杂志, 2015, 30(10): 932-935.
|
26. |
Shiran A, Sagie A. Tricuspid regurgitation in mitral valve disease incidence, prognostic implications, mechanism, and management. J Am Coll Cardiol, 2009, 53(5): 401-408.
|
27. |
Chang CC, Veen KM, Hahn RT, et al. Uncertainties and challenges in surgical and transcatheter tricuspid valve therapy: A state-of-the-art expert review. Eur Heart J, 2020, 41(20): 1932-1940.
|